JAMA Network Home
Sign In
Editor's Note

AI Screening for Subclinical Basal Cell Carcinoma—Early Detection or Overdiagnosis?

JAMA Dermatology 10.1001/jamadermatol.2026.2988

August 19, 2026 at 11:00 AM EDT

Read the full article

In this Editor’s Note, the author highlights the promise of AI-assisted imaging to detect subclinical basal cell carcinoma while cautioning that the natural history and clinical significance of these lesions remain uncertain. The commentary argues that future studies should determine whether earlier detection improves patient outcomes or risks overdiagnosis.

Corresponding Author: Veronica Rotemberg, MD, PhD, Dermatology Service, Memorial Sloan Kettering Cancer Center, 530 E 74th St, New York, NY 10021 (rotembev@mskcc.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2026.2988?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081926

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks